Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -1 | 1 | 4 | 1 | -4 |
| Accounts payable and accrued liabilities | 8 | 0 | 0 | -4 | 3 |
| Other Working Capital | 9 | 2 | 24 | -4 | -1 |
| Other Operating Activity | -26 | -18 | -31 | -13 | -39 |
| Operating Cash Flow | $-9 | $-15 | $-3 | $-21 | $-42 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -8 | 0 | 0 | -41 |
| Investing Cash Flow | $0 | $-8 | $0 | $0 | $-41 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 0 | 0 | -1 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 24 |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $23 |
| Beginning Cash Position | 10 | 31 | 36 | 56 | 116 |
| End Cash Position | 1 | 10 | 31 | 36 | 56 |
| Net Cash Flow | $-9 | $-23 | $-3 | $-21 | $-59 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9 | -15 | -3 | -21 | -42 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -41 |
| Free Cash Flow | -9 | -15 | -3 | -21 | -82 |